(lp0
S"Today's Research Reports on Biotech Stocks to Watch: Array Biopharma and ImmunoGen Yahoo Finance - 22 hours ago Shares of the company fell sharply last month after Array Biopharma announced the withdrawal of its new drug application  for binimetinib monotherapy for the treatment of NRAS-mutant melanoma."
p1
aS"Array Biopharma's 12% Drop, Explained Benzinga - Mar 20, 2017 Shares of Array Biopharma Inc , a biopharmaceutical company that focuses on drugs to treat patients suffering from cancer, lost more than 12 percent early Monday morning after announcing a disappointing update to one of its therapies.Array Biopharma Inc  Withdraws Binimetinib NDA  - Journal Transcript"
p2
aS'What Array BioPharma Inc.  Is Telling Investors Via Its Technical Chart NY Stock News - Apr 11, 2017 Array BioPharma Inc.  has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.How Does Array BioPharma Inc.  Stack Up Right Now? - StockNewsJournalAnalytical Guide for Array BioPharma Inc. , Lexicon Pharmaceuticals, Inc ... - The USA Commerce'
p3
aS'Oversold Conditions For Array BioPharma  Nasdaq - Mar 29, 2017 In trading on Wednesday, shares of Array BioPharma Inc.  entered into oversold territory, hitting an RSI reading of 29.7, after changing hands as low as $9.18 per share.'
p4
aS"What Does The Chart For Array BioPharma Inc.  Tell Us Presently? NY Stock News - Apr 12, 2017 Array BioPharma Inc.  has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment."
p5
aS'Array BioPharma Inc.  Technicals Are Painting A Bleak Picture USA Commerce Daily - 20 hours ago With all other things going on, Array BioPharma Inc.  has been on a free fall - declining -16.32 percent in just three months.'
p6
aS'Looking at the Levels on Shares of Array BioPharma Inc.  Baxter Review - 16 hours ago Market watchers may be taking a closer look at the numbers for Array BioPharma Inc. . ROIC  is a financial metric that can be used to measure how efficient a company is at allocating controlled capital into&nbsp;...'
p7
aS'What Are Analysts Suggestions On Array BioPharma Inc.  News Oracle - 17 hours ago Array BioPharma Inc.  will report its next earnings on May 11 BMO. The company reported the earnings of $-0.14/Share in the last quarter where the estimated EPS by analysts was $-0.18/share.5 Year Capital Spending Growth of Array BioPharma Inc.  is ... - The Newburgh PressArray Biopharma  Receiving Somewhat Favorable News Coverage, Analysis Finds - Markets Daily'
p8
aS"Array BioPharma Inc. : The Technicals As Seen Today NY Stock News - Apr 5, 2017 Array BioPharma Inc.  has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment."
p9
aS'ADX Update on These Shares: Array Biopharma Inc  Rives Journal - Apr 16, 2017 At the time of writing, the 14-day ADX for Array Biopharma Inc  is standing at 41.70. Many chart analysts believe that an ADX reading over 25 would suggest a strong trend.'
p10
a.